2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine
C30H25FN6O — CID 136936761
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine
2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine (PubChem CID 136936761) has the molecular formula C30H25FN6O and a molecular weight of 504.57 g/mol. Its IUPAC name is 2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine.
Molecular Properties
| Compound Name | 2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine |
|---|---|
| PubChem CID | 136936761 |
| Molecular Formula | C30H25FN6O |
| Molecular Weight | 504.57 g/mol |
| Exact Mass | 504.21 |
| IUPAC Name | 2-[5-(5-cyclohexyloxy-3-pyridinyl)-1H-indazol-3-yl]-4-(4-fluorophenyl)-1H-imidazo[4,5-c]pyridine |
| SMILES | Fc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(OC7CCCCC7)c6)cc45)nc23)cc1 |
| InChI | InChI=1S/C30H25FN6O/c31-21-9-6-18(7-10-21)27-29-26(12-13-33-27)34-30(35-29)28-24-15-19(8-11-25(24)36-37-28)20-14-23(17-32-16-20)38-22-4-2-1-3-5-22/h6-17,22H,1-5H2,(H,34,35)(H,36,37) |
| InChIKey | URWJELZHKONCKG-UHFFFAOYSA-N |
| XLogP | 7.08 |
| TPSA | 92.37 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.57 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136936761 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.